Pelvic lymph node dissection for prostate cancer: Adherence and accuracy of the recent guidelines

International Journal of Urology

Volumn 20, Issue 4, 2013, Pages 405-410

  Abdollah, Firas ^a,b   Abdo, Al'a ^a   Sun, Maxine ^a   Schmitges, Jan ^a,c   Tian, Zhe ^a   Briganti, Alberto ^b   Shariat, Shahrokh F ^d   Perrotte, Paul ^a   Montorsi, Francesco ^b   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Epidemiology and End Results program; Lymph node excision statistics and numerical data; Lymphatic metastasis diagnosis; Pelvis; Prostatic neoplasm pathology; Surveillance

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REFERENCE VALUE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; GUIDELINE ADHERENCE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; PRACTICE GUIDELINES AS TOPIC; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84875805414     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03171.x     Document Type: Article

References (15)

1. NCCN Clinical Practice Guidelines in Oncology, Prostate cancer. 2010. [Cited 20 Aug 2010.] Available from URL: http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf
2. Cagiannos I, Karakiewicz P, Eastham JA etal. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J. Urol. 2003; 170: 1798-1803.
3. Heidenreich A, Bolla M, Joniau S etal. European Association of Urology, Guidelines on Prostate Cancer. 2010. [Cited 20 Aug 2010.] Available from URL: http://www.uroweb.org/professional-resources/guidelines/
4. Briganti A, Chun FK, Salonia A etal. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int. 2006; 98: 788-793.
5. Carroll P, Coley C, McLeod D etal. Prostate-specific antigen best practice policy - part II: prostate cancer staging and post-treatment follow-up. Urology 2001; 57: 225-229.
6. Thompson I, Thrasher JB, Aus G etal. Guideline for the management of clinically localized prostate cancer: 2007 update. J. Urol. 2007; 177: 2106-2131.
7. Horner MJ, Ries LAG, Krapcho M etal. (eds.) SEER Cancer Statistics Review, 1975-2004. National Cancer Institute, Bethesda, MD, 2007. [Cited November 2006.] Available from URL: http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER Web site.
8. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 1117-1121.
9. Harlan LC, Hankey BF. The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J. Clin. Oncol. 2003; 21: 2232-2233.
10. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843-848.
11. Abdollah F, Sun M, Thuret R etal. Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer. Eur. Urol. [Research Support, Non-U.S. Gov't]. 2010; 58: 882-892.
12. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J. Urol. 2003; 169: 946-950.
13. Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008; 112: 2401-2408.
14. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J. Urol. 2004; 172 (5 Pt 1): 1840-1844.
15. Briganti A, Blute ML, Eastham JH etal. Pelvic lymph node dissection in prostate cancer. Eur. Urol. 2009; 55: 1251-1265.